Call for Papers
Cancer Innovation is an open access and peer-reviewed journal devoted to publishing high‐quality original articles, reviews, clinical guidelines, technical reports, editorials, case reports, commentaries, news, study protocols and meta-analyses. This journal highlights the multidisciplinary integration in innovative oncology and aims to promote interdisciplinary oncology research and management of comorbidities across medical subspecialties. With this journal, we hope to begin a journey to find the solutions to innovative oncology problems, establish a hub for collaboration and communication across disciplines, and present a high-quality platform for deepening our understanding of oncology and developing guidelines for clinical decisions.
You are invited to contribute to Cancer Innovation, which is intended to provide an unique platform for researchers to present combination of oncology translational research, inter-specialty integration, and data sciences, bringing us one step closer to precision oncology and a better future for cancer patients.
Academic Sections
Basic Cancer Research, Clinical Cancer Research, Oncological Pharmacology, Oncologic Imaging, Cancer Genomics, Cancer Informatics, Artificial Intelligence Application, and Cardioncology.
Here are 5 reasons why Cancer Innovation is the right platform for your next paper:
- Your research will be free to access, making it available to read, download and share with ease.
- Quality and impactful research governed by an international and distinguished editorial board.
- Publish open access at no cost to you-fees are waived from 2022-2024.
- An official journal of the Boao Cancer Innovation Institute, devoted to innovative and significant research in basic research and clinical oncology, and published on behalf of Tsinghua University Press.
- Save time formatting your manuscript with free formatting submission.
How to submit
Manuscripts should be written in accordance with the Author Guidelines and submitted via the online submission system.
Please email [email protected] with any questions. Look forward to your submission!